Evidence map›Paper›PMID 28586943›Full record

ArticleThe Journal of clinical endocrinology and metabolism2017

Oxytocin and Its Relationship to Body Composition, Bone Mineral Density, and Hip Geometry Across the Weight Spectrum.

Melanie Schorr, Dean A Marengi, Reitumetse L Pulumo, Elaine Yu, Kamryn T Eddy, Anne Klibanski, Karen K Miller, Elizabeth A Lawson

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Brain serotonin, oxytocin, and their interaction: Relevance for eating disorders.Journal of psychopharmacology (Oxford, England) · 2025
    Review
  9. Article
  10. Observational
  11. Review
  12. Oxytocin and women's health in midlife.The Journal of endocrinology · 2024
    Review
  13. Review
  14. The Effect of Oxytocin on Osteoporosis Improvement: A Systematic Review.Medical journal of the Islamic Republic of Iran · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Highly Specific Detection of Oxytocin in Saliva.International journal of molecular sciences · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Melanie SchorrNeuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114.
Dean A MarengiNeuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114.
Reitumetse L PulumoNeuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114.
Elaine YuHarvard Medical School, Boston, Massachusetts 02115.
Kamryn T EddyHarvard Medical School, Boston, Massachusetts 02115.
Anne KlibanskiNeuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114.
Karen K MillerNeuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114.
Elizabeth A LawsonNeuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114.
Massachusetts General Hospital · USHarvard University · US

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI CHRISTOPHER P DUGGAN · 1994 to 2026
$31.6M
TRAINING PROGRAM IN ENDOCRINOLOGY AND DIABETEST32DK007028 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Karen K Miller · 1986 to 2026
$18.5M
Hormones/Genes in Women's Health: From Bench to BedsideK12HD051959 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI GOLDSTEIN, JILL M, REXRODE, KATHRYN M · 2005 to 2023
$8.8M
IGF-I AND BONE LOSS IN WOMEN WITH ANOREXIA NERVOSAR01DK052625 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KLIBANSKI, ANNE · 1997 to 2015
$6.9M
Growth Hormone and Cardiovascular DiseaseK24HL092902 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MILLER, KAREN K · 2010 to 2019
$1.6M
Appetite-regulating Hormones and Neurocircuitry in Anorexia NervosaK23MH092560 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI LAWSON, ELIZABETH AUSTEN · 2011 to 2015
$935k
NCRR NIH HHS UL1 RR025758NHLBI NIH HHS K24 HL092902NICHD NIH HHS K12 HD051959NIDDK NIH HHS P30 DK040561NIDDK NIH HHS R01 DK052625NIDDK NIH HHS T32 DK007028NIMH NIH HHS K23 MH092560
6 · The paper itself

Abstract

Context: Oxytocin (OXT), an anorexigenic hypothalamic hormone anabolic to bone, may reflect energy availability. Basal serum OXT levels are lower in anorexia nervosa (AN, state of energy deficit) than healthy controls (HC) and negatively associated with spine bone mineral density (BMD). Reports are conflicting regarding OXT levels in overweight/obesity (OB, state of energy excess). Relationships between OXT and BMD in OB and hip geometry across the weight spectrum are unknown. Objective: To determine whether overnight serum OXT levels are (1) elevated in OB and (2) associated with body composition, BMD, and hip geometry across the weight spectrum. Design: Cross-sectional. Setting: Clinical research center. Participants: Fifty-nine women, ages 18 to 45 years: amenorrheic AN (N = 16), eumenorrheic HC (N = 24), eumenorrheic OB (N = 19). Main Outcome Measures: Serum sampled every 20 minutes from 8 pm to 8 am and pooled for integrated overnight OXT levels. Body composition, BMD, and hip structural analysis measured by dual x-ray absorptiometry. Results: OXT levels were lowest in AN, higher in HC, and highest in OB (P ≤ 0.02). There were positive associations between OXT and (1) body mass index (P = 0.0004); (2) total, visceral, and subcutaneous fat (P ≤ 0.0002); (3) spine and hip BMD Z-scores (P ≤ 0.01); and (4) favorable hip geometry, namely buckling ratio (P ≤ 0.05). In a subset analysis of HC and OB, relationships between OXT and body composition, but not bone parameters, remained significant. Conclusions: These data suggest OXT is a marker of energy availability and may be a mediator of bone density, structure, and strength. OXT pathways may provide targets for obesity and osteoporosis treatment.

Indexed as

Body CompositionBone DensityAbsorptiometry, PhotonAdultAnorexia NervosaBody Mass IndexCross-Sectional StudiesFemaleHipHumansIntra-Abdominal FatObesityOxytocinSpineSubcutaneous FatYoung AdultOxytocin

Identifiers

PMID28586943
PMCPMC5546854
OpenAlexW2613202043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.